576 related articles for article (PubMed ID: 22605933)
1. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
[TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers.
Gokce EH; Korkmaz E; Tuncay-Tanrıverdi S; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():5109-17. PubMed ID: 23055723
[TBL] [Abstract][Full Text] [Related]
3. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
Neves AR; Lúcio M; Martins S; Lima JL; Reis S
Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
[TBL] [Abstract][Full Text] [Related]
4. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.
Barbosa JP; Neves AR; Silva AM; Barbosa MA; Reis MS; Santos SG
Int J Nanomedicine; 2016; 11():3501-16. PubMed ID: 27555771
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
[TBL] [Abstract][Full Text] [Related]
10. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
Teskac K; Kristl J
Int J Pharm; 2010 May; 390(1):61-9. PubMed ID: 19833178
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic coating of mitotane-loaded lipid nanoparticles: preliminary studies for mucosal adhesion.
Severino P; Souto EB; Pinho SC; Santana MH
Pharm Dev Technol; 2013; 18(3):577-81. PubMed ID: 21958059
[TBL] [Abstract][Full Text] [Related]
12. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
[TBL] [Abstract][Full Text] [Related]
14. Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.
Shrotriya SN; Ranpise NS; Vidhate BV
Drug Deliv Transl Res; 2017 Feb; 7(1):37-52. PubMed ID: 27981502
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the possible cytotoxic effects of different nanostructured lipid carrier (NLC) compositions in human dermal fibroblasts.
Brugè F; Damiani E; Marcheggiani F; Offerta A; Puglia C; Tiano L
Int J Pharm; 2015 Nov; 495(2):879-85. PubMed ID: 26392245
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.
Ruktanonchai U; Bejrapha P; Sakulkhu U; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
AAPS PharmSciTech; 2009; 10(1):227-34. PubMed ID: 19280350
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.
Pathak P; Nagarsenker M
AAPS PharmSciTech; 2009; 10(3):985-92. PubMed ID: 19641997
[TBL] [Abstract][Full Text] [Related]
18. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
Suter F; Schmid D; Wandrey F; Zülli F
Eur J Pharm Biopharm; 2016 Nov; 108():304-309. PubMed ID: 27343822
[TBL] [Abstract][Full Text] [Related]
19. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
Wu KW; Sweeney C; Dudhipala N; Lakhani P; Chaurasiya ND; Tekwani BL; Majumdar S
AAPS PharmSciTech; 2021 Sep; 22(7):240. PubMed ID: 34590195
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery.
Korkm E; Gokce EH; Ozer O
Acta Pharm; 2013 Dec; 63(4):517-29. PubMed ID: 24451076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]